NEW YORK (GenomeWeb) – Canadian molecular diagnostics firm GeneNews today reported a steep increase in its first quarter revenues.

For the three months ended March 31, the Toronto-based firm said that revenues improved to C$201,852 (US$185,445) from C$48,348 in the year-ago quarter. All revenues in the recently completed quarter were generated from royalty payments. GeneNews recorded no test revenues in Q1 2014 compared to C$912 in Q1 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.